The hepatitis B virus is a potent pathogen capable of inducing chronic infections that lead to multiple liver diseases, including acute and chronic hepatitis, cirrhosis, and particularly primary hepatocellular carcinoma, which poses a significant health threat in the Asia-Pacific region. Although currently approved antiviral therapies (including pegylated interferon [IFN] and nucleoside...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek